IL-2, IL-6 and IL-8 levels remain unaltered in the course of immunosuppressive therapy after renal transplantation

• Autorzy: Jacek Rysz , Eugeniusz Kocur , Robert Blaszczak , Piotr Bartnicki , Robert Stolarek , Mariusz Piechota
• Języki publikacji: EN

Abstrakty

EN

Cytokines regulate the immune reactions elicited by renal transplantation (RT). This study was designed to investigate the blood serum levels of IL-2, IL-6, IL-8 in 25 RT patients (10 female and 15 male, mean 5.4±2.7 yrs after RT) three times over a six-month period during standard immunosuppressive therapy with cyclosporine A, azathioprine and prednisolone. The levels of IL-2, IL-6 and IL-8 were tested with ELISA Quantikine Human Interleukin Immunoassay (R&D Systems, detection level 7,0.7 and 10 pg/cm3, respectively). There was no significant alternation of blood serum levels of IL-2, IL-6 and IL-8 in the study patients.

Słowa kluczowe

EN

Cytokines; Lymphocytes; Transplantation; Immune system

• Czasopismo: Open Medicine
• Rocznik: 2008
• Tom: 3
• Numer: 2
• Strony: 199-202

Daty

wydano

2008-06-01

online

2008-04-09

Twórcy

autor

Jacek Rysz

• 2nd Department of Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland,

autor

Eugeniusz Kocur

• 2nd Department of Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland

autor

Robert Blaszczak

• 2nd Department of Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland

autor

Piotr Bartnicki

• 2nd Department of Family Medicine, Medical University of Lodz, 90-549, Lodz, Poland

autor

Robert Stolarek

• Department of Experimental and Clinical Physiology, Medical University of Lodz, 92-215, Lodz, Poland

autor

Mariusz Piechota

• Department of Anaesthesiology and Intensive Care Unit, University Hospital No. 5 in Lodz, Medical University of Lodz, 90-647, Lodz, Poland

Bibliografia

• [1] Whicher J.T., Evans S.W., Cytokines in disease, Clin. Chem., 1990, 36, 1269–1281
• [2] Rysz J., Banach M., Ciałkowska-Rysz A., Stolarek R., Drozdz J., Okoński P., Blood serum levels of IL-2, IL-6, IL-8, TNF-a and IL-1b in patients on maintenance hemodialysis, Cell. Mol. Immunol., 2006, 3, 151–154
• [3] Descamps-Latscha B., Herbelin A., Nguyen A.T., Roux-Lombard P., Zingraff J., Moynot A., et al., Balance between IL-1b, TNF-a, and their specific inhibitors in chronic renal failure and maintenance dialysis, J. Immunol., 1995, 154, 882–892
• [4] Bock G.H., Neu L., Long C., Patterson L.T., Korb S., Gelpi J., et al., Assessment of serum and urine soluble interleukin-2 receptor concentration during renal transplant rejection, Am. J. Kidney Dis., 1994, 23, 421–426 [Crossref]
• [5] Dobbelstein H., Immune system in uremia, Nephron, 1976, 17, 409–414 [Crossref]
• [6] Kang X., Hirano T., Oka K., Tamak T., Samurai E., Kaji N., et al., Recovery of decreased ability of peripheral-blood mononuclear cells from chronic renal failure to produce interleukin-1 after renal transplantation. Nephron, 1991, 58, 450–455 http://dx.doi.org/10.1159/000186478[Crossref]
• [7] Rysz J., Stolarek R.A., Majewska E., Banach M., Cialkowska-Rysz A., Baj Z., The increased levels of soluble TNFa receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis, Am. J. Nephrol., 2006, 26, 437–444 http://dx.doi.org/10.1159/000095902[Crossref]
• [8] Allegre M.L., Costimulatory molecules as targets for the induction of transplantation tolerance, Nephrol. Dial. Transplant., 1999, 14, 322–332 http://dx.doi.org/10.1093/ndt/14.2.322[Crossref]
• [9] Jakóbisiak M.,Immunologia. Wydawnictwo Naukowe PWN, Warszawa, Poland, 141–145, 478–524, 1993
• [10] Schwarz C., Oberbauer R., The influence of organ donor factors on early allograft function, Curr. Opin. Urol., 2003, 13, 99–104 http://dx.doi.org/10.1097/00042307-200303000-00003[Crossref]
• [11] Hermelin A., Urena P., Nguyen A.T., Zingraff J., Descamps-Latscha B., Elevated circulating levels of interleukin-6 in patients with chronic failure, Kidney Int., 1991, 39, 954–960 http://dx.doi.org/10.1038/ki.1991.120[Crossref]
• [12] Kutuckuler N., Clark K., Rigg K.M., The value of posttransplant monitoring of IL-2, IL-3, IL-4, IL-6, IL-8 and soluble CD23 in the plasma of renal allograft recipients, Transplantation, 1995, 59, 333–337
• [13] Budde K., Waiser J., Ceska J., Katalinic A., Kürzdörfer M., Neumayer H.H., Interleukin-8 expression in patients after renal transplantation, Am. J. Kidney Dis., 1997, 29, 871–875 http://dx.doi.org/10.1016/S0272-6386(97)90461-3[Crossref]
• [14] Boratynska M., Urine and serum levels of interleukin-8 in patients after renal transplantation, Przegl. Lek. 1998, 55, 576–580
• [15] Waiser J., Budde K., Katalinic A., Kuerzdörfer M., Riess R., Neumayer H.H., Interleukin-6 expression after renal transplantation. Nephrol. Dial. Transplant., 1997, 12, 753–759 http://dx.doi.org/10.1093/ndt/12.4.753[Crossref]
• [16] Noronha I., Niemir Z., Stein H., Waldherr R., Cytokines and growth factors in renal disease, Nephrol. Dial. Transplant., 1995, 10, 775–786
• [17] Bachórzewska-Gajewska H., Małyszko J., Sitniewska E., Małyszko J., Dobrzycki S., Prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary interventions in everyday clinical practice, Arch. Med. Sci., 2006, 2, 256–261
• [18] Rysz J., Stolarek R., Banach M., Pasnik J., Okoński P., Baj Z., et al. TNF-alfa priming effect on polymorphonuclear leukocytes reactive species generation and adhesion molecule expression in hemodialyzed patients, Arch. Immunol. Ther. Exp., 2006, 54, 209–215 http://dx.doi.org/10.1007/s00005-006-0023-1[Crossref]
• [19] Rysz J., Kocur E., Błaszczak R., Stolarek R., Integrin CD11a/CD18, CD11b/CD18 and CD69 expression in patients after renal transplantation, Cent. Eur. J. Med., 2007, 2, 154–158 http://dx.doi.org/10.2478/s11536-007-0015-5[WoS][Crossref]

Identyfikatory

DOI

10.2478/s11536-008-0011-4